View in EDS HTML Full Text PDF Full Text

A novel two-step administration of XPO-1 inhibitor may enhance the effect of anti-BCMA CAR-T in relapsed/refractory extramedullary multiple myeloma.

Saved in:
Bibliographic Details
Title: A novel two-step administration of XPO-1 inhibitor may enhance the effect of anti-BCMA CAR-T in relapsed/refractory extramedullary multiple myeloma.
Authors: Wang, Di1,2 (AUTHOR), Fu, Haiying3 (AUTHOR), Que, Yimei1 (AUTHOR), Ruan, Haitao1,2 (AUTHOR), Xu, Menglei1 (AUTHOR), Long, Xiaolu1,2 (AUTHOR), Yu, Qiuxia1 (AUTHOR), Li, Chunhui1 (AUTHOR), Li, Zhe1 (AUTHOR), Cai, Songbai4 (AUTHOR), Chen, Wei5 (AUTHOR), Sun, Cong5 (AUTHOR), Hu, Guang4 (AUTHOR), Wang, Shuai5 (AUTHOR), He, Donggou4 (AUTHOR), Mei, Jianming5 (AUTHOR), Wang, Wen4 (AUTHOR), Li, Chunrui1,2 (AUTHOR) cunrui5650@hust.edu.cn
Source: Journal of Translational Medicine. 11/15/2023, Vol. 21 Issue 1, p1-10. 10p.
Database: Academic Search Ultimate
Full text is not displayed to guests.
Description
ISSN:14795876
DOI:10.1186/s12967-023-04655-w